Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG) (the “Company”), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that Andrew L. Pearlman, Ph.D., President and Chief Executive Officer of Medgenics, will be presenting a corporate overview at the 8th Annual JMP Securities Healthcare Conference on Wednesday, July 10th at 12:00 noon Eastern time at The St. Regis New York.
Help employers find you! Check out all the jobs and post your resume.
